You have 9 free searches left this month | to do more

Decitabine

Decitabine is a drug used to treat Acute Myeloid Leukemia, Myelodysplastic Syndrome, Myelodysplastic Syndromes, and other conditions. Decitabine is being actively studied in 79 studies and prior, has been studied in 93.

Top SponsorsTop SitesTop Investigators
M.D. Anderson Cancer CenterUniversity of Texas MD Anderson Cancer CenterHan weidong
National Cancer Institute (NCI)M D Anderson Cancer CenterQifa Liu
Eisai Inc.Roswell Park Cancer InstituteMing Hou
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
C
Active, not recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Decitabine
  • +3 more
  • Duarte, California
    City of Hope Medical Center
2022-02-17
Feb 17, 2022
N
Suspended
  • Acute Myeloid Leukemia
  • Decitabine
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
2022-04-05
Apr 5, 2022
S
Terminated
  • Breast Neoplasm
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai Jiaotong University School of Medicine
2022-03-28
Mar 28, 2022
M
Recruiting
  • Chronic Myelomonocytic Leukemia
  • +3 more
  • Decitabine
  • Tagraxofusp-erzs
  • Houston, Texas
    M D Anderson Cancer Center
2022-03-04
Mar 4, 2022
N
Active, not recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
2022-03-31
Mar 31, 2022
C
Not yet recruiting
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Decitabine
  • +2 more
  • Duarte, California
    City of Hope Comprehensive Cancer Center
2022-02-08
Feb 8, 2022
U
Active, not recruiting
  • Acute Myelogenous Leukemia
  • Decitabine
  • Rochester, New York
    University of Rochester
2021-12-08
Dec 8, 2021
T
Withdrawn
  • Myelodysplastic Syndromes (MDS)
  • (no location specified)
2021-09-23
Sep 23, 2021
M
Completed
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2022-01-13
Jan 13, 2022
S
Active, not recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • STAT Inhibitor OPB-111077
  • +3 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
2022-02-04
Feb 4, 2022
V
Active, not recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Sarcoma
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
2021-12-03
Dec 3, 2021
J
Recruiting
  • COVID-19
  • Decitabine
  • Placebo Saline
  • Baltimore, Maryland
    Johns Hopkins University
2022-02-07
Feb 7, 2022
C
Recruiting
  • Childhood Solid Tumor
  • +5 more
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
2022-02-13
Feb 13, 2022
C
Recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Decitabine
  • +2 more
  • Duarte, California
    City of Hope Comprehensive Cancer Center
2022-03-09
Mar 9, 2022
U
Recruiting
  • Acute Myeloid Leukemia
  • +8 more
  • Decitabine
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2022-02-25
Feb 25, 2022
U
Active, not recruiting
  • Acute Myeloid Leukemia
  • Baltimore, Maryland
    University of Maryland Greenebaum Comprehensive Cancer Center
2021-10-05
Oct 5, 2021
W
Active, not recruiting
  • Acute Myeloid Leukemia
  • Acute Myeloid Leukemia, Relapsed, Adult
  • Decitabine
  • +4 more
  • Saint Louis, Missouri
    Washington University School of Medicine
2022-02-18
Feb 18, 2022
U
Recruiting
  • PTCL
  • CTCL
  • Charlottesville, Virginia
    University of Virginia
2022-02-10
Feb 10, 2022
I
Recruiting
  • Refractory Aplastic Anemia
  • Decitabine
  • Tianjin, Tianjin, China
    Regenerative Medicine Center
2021-05-10
May 10, 2021
B
Recruiting
  • Myelodysplastic Syndromes
  • MDS/MPN Crossover Syndromes
  • Cleveland, Ohio
    Cleveland Medical Center, University Hospitals Seidman Cancer Ce
2021-08-19
Aug 19, 2021
M
Active, not recruiting
  • Myelodysplastic Syndromes
  • decitabine
  • +6 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
2021-05-07
May 7, 2021
R
Active, not recruiting
  • Recurrent Fallopian Tube Carcinoma
  • +2 more
  • Aldesleukin
  • +4 more
  • Buffalo, New York
    Roswell Park Cancer Institute
2022-03-03
Mar 3, 2022
Y
Terminated
  • ACUTE MYELOID LEUKEMIA
  • New Haven, Connecticut
    Yale Cancer Center/Smilow
2021-09-18
Sep 18, 2021
S
Completed
  • Response Rate
  • Decitabine
  • Shanghai, Shanghai, China
    Blood & Marrow Transplantation Center, RuiJin Hospital
2021-05-19
May 19, 2021